Michael Andersson
University of Copenhagen(DK)Copenhagen University Hospital(DK)Rigshospitalet(DK)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Risks and Factors, Advanced Breast Cancer Therapies
Most-Cited Works
- → Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
- → Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial(1999)1,608 cited
- → Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors(2005)828 cited
- → Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study(2009)688 cited
- → Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease(2003)656 cited
- → Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years(2002)560 cited